migraine

(redirected from Migrane)
Also found in: Dictionary, Thesaurus, Medical.

migraine

(mī`grān), headache characterized by recurrent attacks of severe pain, usually on one side of the head. It may be preceded by flashes or spots before the eyes or a ringing in the ears, and accompanied by double vision, nausea, vomiting, or dizziness. The attacks vary in frequency from daily occurrences to one every few years.

Migraine affects women three times as often as men and is frequently inherited. Many disturbances, such as allergy, temporary swelling of the brain, and endocrine disturbances, have been suspected of causing some varieties of the disorder. Although the exact cause is unknown, evidence suggests a genetically transmitted functional disturbance of cranial circulation. The pain is believed to be associated with constriction followed by dilation of blood vessels leading to and within the brain.

Untreated attacks may last for many hours. Mild attacks are often relieved by common sedatives such as aspirin or codeine. Severe attacks may be treated with any of a variety of drugs, including a group called triptans, by injection or in the form of pills or nasal sprays. Certain beta-blockers, antiepileptic drugs, or tricyclic antidepressants may reduce the recurrence of migraines in some patients. Biofeedback is used in training people to recognize the warning symptoms and to practice control over the vascular dilation that initiates attacks.

Migraine

 

(also hemicrania), a condition characterized by periodic headaches, usually localized in one half of the head. Women are most often affected by migraines, and in the majority of cases there is a hereditary tendency. The condition usually begins to manifest itself during puberty.

Migraines originate with changes in the tonus of intracranial and extracranial vessels. It is conjectured that first there is a spasm in the vessels and then a decrease in their tonus. As a result, the vessels dilatate abnormally. The headache attacks are accompanied by nausea, vomiting, and photophobia. Other symptoms include pallor or flushing, chilled hands and feet, weakness, shivering, and yawning. Patients usually complain of seeing bright flashes and zigzag lines; sometimes there is reduction or dimness of vision (ophthalmic migraine). Other symptoms are numbness of or tingling sensations in the extremities and, sometimes, the face and tongue. The symptomatic migraine is an indication of organic brain disease—for example, tumor, or vascular aneurysm.

Treatment entails normalization of vascular tonus, sedatives, and physical therapy.

WORKS

Davidenkov, S. N., and A. M. Godinova. “K voprosu o nozologicheskikh granitsakh migrenei.” In Ocherki klinicheskoi nevrologii, fasc. 2. [Leningrad] 1964. [Collection of works.]

V. A. KARLOV

migraine

[′mī‚grān]
(medicine)
Recurrent paroxysmal vascular headache, commonly having unilateral onset and often associated with nausea and vomiting.

migraine

a throbbing headache usually affecting only one side of the head and commonly accompanied by nausea and visual disturbances
References in periodicals archive ?
Two pharmaceutical companies are considering using Denver's Terrell Davis as a spokesman, considering that he made such a remarkable comeback from a second-quarter migrane headache to win the MVP award in the recent Super Bowl.
Pilotstudie zur magnesiumtherapie bei migrane und spannungskopfschmerz.
Epidemiological data on the Patent Foramen Ovale (PFO) and its association with migrane
Mancienne missed the 1-0 win at Doncaster with a migrane and was replaced by Neill Collins, who rose to the occasion in the 81st minute to steal a goal and all three points, but Mancienne is now fit and will be considered for this afternoon's visit of Sheffield United.
In-form forward Eorl Crabtree, who has been making such a devastating impact from the bench this season, has now made a full recovery from the bout of migrane attacks which forced him to miss the Salford trip.
POZEN and Xcel Pharmaceuticals announced in September 2003 that they signed a licensing agreement for the commercialization of MT 300, an injectable product candidate for the treatment of migrane.